What Is Vazalore Used For: Conditions It Treats

Vazalore is a brand-name aspirin designed to protect your heart with less damage to your stomach. It comes in two strengths, 81 mg and 325 mg, and is used for the same purposes as traditional aspirin: reducing the risk of heart attack and stroke, relieving pain, and lowering fever. What sets it apart is its delivery system, which wraps aspirin in a lipid (fat-based) coating that helps it pass through the stomach lining more gently.

How Vazalore Differs From Regular Aspirin

At its core, Vazalore is still aspirin. The active ingredient is identical. The difference is in how it reaches your bloodstream. Traditional aspirin dissolves directly against your stomach lining, which can cause irritation, erosions, and ulcers over time. This is especially problematic for people who take a daily low-dose aspirin for heart protection, since that means years of exposure.

Vazalore uses a formulation where aspirin is bound to a pharmaceutical lipid called phosphatidylcholine, making it more fat-soluble. This helps the aspirin move across the stomach’s protective mucous layer rather than sitting on its surface and eating into it. The result: equivalent absorption and blood-thinning effects, but significantly less gastric damage.

You might wonder why older alternatives like enteric-coated or buffered aspirin don’t solve the same problem. Despite decades of marketing, those formulations have not been shown to meaningfully reduce aspirin-related stomach injury. Worse, enteric-coated aspirin has demonstrated incomplete absorption and a weaker effect on platelets in some patients, which defeats the purpose of taking it in the first place. Vazalore’s liquid-filled capsule avoids both of those pitfalls.

Cardiovascular Prevention

The primary reason people take Vazalore is to prevent a first or recurrent heart attack or stroke. Daily low-dose aspirin (81 mg) works by inhibiting platelets, the small blood cells that clump together to form clots. In people with narrowed or damaged arteries, those clots can block blood flow to the heart or brain. By keeping platelets from sticking together as easily, aspirin lowers that risk.

Vazalore is not a new class of drug and is not separately mentioned in current cardiovascular guidelines from the American College of Cardiology or American Heart Association. Those guidelines recommend “aspirin” broadly, and Vazalore qualifies. It is most commonly used by people already advised to take daily aspirin, particularly those who have experienced stomach problems with plain aspirin or who are at higher risk for gastrointestinal bleeding.

For secondary prevention (meaning you’ve already had a heart attack, stroke, or been diagnosed with cardiovascular disease), daily aspirin is well established. For primary prevention (meaning you haven’t had a cardiovascular event), the decision is more nuanced. Low-dose aspirin increases the risk of major gastrointestinal bleeding by about 58% and raises hemorrhagic stroke risk modestly. Those risks are higher in older adults, men, and people whose cardiovascular risk factors also increase bleeding risk. The choice to start daily aspirin requires weighing your personal heart risk against your personal bleeding risk.

Stomach Protection: What the Data Shows

The most compelling case for choosing Vazalore over plain aspirin is the stomach safety data. In a clinical trial comparing Vazalore 325 mg to immediate-release aspirin over seven days, Vazalore reduced the risk of stomach erosions or ulcers by 47%. The risk of ulcers specifically dropped by 71%. In practical terms, for every eight people switched from regular aspirin to Vazalore, one additional person avoided developing an ulcer.

These are meaningful numbers for anyone taking aspirin daily over months or years. Stomach erosions from aspirin don’t always cause obvious symptoms. They can bleed slowly, leading to anemia, or they can progress to full ulcers that require medical intervention. If you’ve been told to stay on daily aspirin but have a history of stomach ulcers, acid reflux, or GI bleeding, the lipid-aspirin formulation addresses a real clinical gap that enteric coating and buffering never successfully filled.

Pain Relief and Fever Reduction

Vazalore 325 mg is also approved for temporary relief of minor aches and pains, including headaches, muscle pain, toothaches, and menstrual cramps, as well as for reducing fever. At this strength, the dosing directions allow 1 or 2 capsules every 4 hours, or 3 capsules every 6 hours, up to a maximum of 12 capsules in 24 hours. This is the same kind of short-term, as-needed use you’d associate with any over-the-counter aspirin.

For occasional pain relief, the stomach-protection advantage is less dramatic than it is for daily long-term use. A few days of aspirin rarely causes significant gastric damage in most people. But if you’re someone who reaches for aspirin periodically and has a sensitive stomach, the gentler formulation can still matter.

Who Should Be Cautious

Because Vazalore is aspirin, it carries all of aspirin’s risks. The lipid coating reduces stomach surface injury, but aspirin also inhibits protective compounds called prostaglandins throughout the body, which contributes to bleeding risk systemically. Vazalore does not eliminate the risk of gastrointestinal bleeding; it reduces local stomach damage specifically.

People at elevated bleeding risk include those taking blood thinners, those with a history of bleeding disorders, heavy alcohol users, and adults over 70. Anyone with a known aspirin allergy or sensitivity should avoid Vazalore entirely, just as they would any aspirin product. Children and teenagers recovering from flu-like illnesses or chickenpox should not take aspirin due to the risk of Reye’s syndrome, a rare but serious condition affecting the liver and brain.

If you’re currently taking enteric-coated aspirin for heart protection, Vazalore offers a comparable blood-thinning effect. A crossover study comparing the two found no significant difference in aspirin resistance rates: about 15% of people on Vazalore and 19% on enteric-coated aspirin showed reduced platelet response. Neither formulation was clearly superior in terms of antiplatelet effectiveness, but Vazalore avoids the absorption inconsistencies that have been documented with enteric-coated products.

Cost and Availability

Vazalore is available over the counter in both 81 mg and 325 mg capsules. Because it is a branded product with a proprietary delivery system, it costs more than generic aspirin or store-brand enteric-coated aspirin. For people taking it daily for cardiovascular prevention, the price difference adds up over time. Whether that extra cost is worth it depends largely on your individual stomach risk. If you’ve tolerated plain aspirin without GI issues for years, the clinical benefit of switching may be modest. If you’ve had stomach problems or are at high risk for them, the reduction in erosions and ulcers represents a tangible advantage that cheaper formulations have failed to deliver.